UMMS is developing a toolkit to help community health centers determine whether their emergency preparedness plans address the needs of individuals with disabilities and to assess other potential emergency planning gaps.
Katherine A. Fitzgerald, PhD, has been named a Thomson Reuters Highly Cited Researcher for being one of the world’s most influential and highly cited scientists.
The RNA Therapeutics Institute has been accorded department status and Phillip D. Zamore, PhD, has been appointed founding chair. The change to department status is a result of the successes of the RTI since it was formed in 2009.
Peter Lawrence Jones, PhD, credits the Chris Carrino Foundation for Facioscapulohumeral Muscular Dystrophy for funding that helped lead to a breakthrough in his lab, according to a Yahoo Sports video profiling Carrino, the Brooklyn Nets radio announcer who has FSHD.
According to a study published in Nature Biotechnology, a more efficient delivery of a CRISPR/Cas9 therapeutic to adult mice with the metabolic disease Tyrosinemia type I developed by Wen Xue, PhD, may also prove to be safer for use in humans.
A new study found that activation of a particular immune response in pregnant mice alters the brain structure of the mouse offspring and causes behavioral changes reminiscent of those observed in humans with autism. The research was published in Science. Jun Huh, PhD, is a corresponding author.
In an interview with MedPage Today, UMass Medical School skin cancer expert Mary Maloney, MD, hailed a new study which found that almost 100 percent of women with a melanoma diagnosis before age 30 had used indoor tanning facilities.
The 2015 UMass Medicine Cancer Walk & 5K Run raised more than $420,000 for the UMass Medicine Cancer Center to support research and patient care.
A new type of optogenetic technology is capable of turning on immune cells to attack melanoma tumors in mice. Using near-infrared light, Gang Han, PhD, has shown that an immune response can be selectively activated by controlling the flow of calcium ions into the cell. This breakthrough could lead to less invasive and more selective immunotherapies for cancer.
UMass Medical School perinatal depression expert Nancy Byatt, DO, MBA, fully supports the new U.S. Preventive Services Task Force recommendation that all adults including pregnant and postpartum women be screened for depression and provided follow-up care and treatment.